Blog

Why Adaptimmune Therapeutics Was Sinking This Week

In an about-face from its impressive performance last week, Adaptimmune Therapeutics (NASDAQ: ADAP) stock declined by nearly 14% over the past five trading days. This occurred even though the

TheMotleyFool

0

Why Avalanche, Polkadot, and Solana Are Seeing Wild Trading Action This Week

Avalanche (CRYPTO: AVAX), Polkadot (CRYPTO: DOT), and Solana (CRYPTO: SOL) are up 33.03% and 12.56% and down 22.75%, respectively, in the past seven days, as of 2:47 p.m. EDT on Friday. They are now

TheMotleyFool

0

Why All the Uranium Stocks Crashed Today

After enjoying a nice run-up earlier in the week, uranium stocks melted down on Friday. As of 3:30 p.m. EDT, shares of uranium mining company Energy Fuels (NYSEMKT: UUUU) are down 10%, NexGen Energy

TheMotleyFool

0

3 No-Brainer Buffett Stocks to Invest $300 in Right Now

If you follow stocks, then you've undoubtedly heard of legendary investor Warren Buffett and his conglomerate Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B). Inside Berkshire Hathaway is an equities

TheMotleyFool

0

Why Virgin Galactic Stock Popped Today

You might think that, two days after SpaceX launched four humans into the farthest reaches of space since the Apollo missions, customers' interest in paying $250,000 to $450,000 a ticket for a brief

TheMotleyFool

0

Why Facebook Stock Dropped Again Today

And the hits just keep on coming for Facebook (NASDAQ: FB) -- in a bad way.

Earlier this week, Facebook stock was slammed when it became apparent that The Wall Street Journal is publishing a

TheMotleyFool

0

Why Plug Power Stock Popped Today

As the trading week wound down Friday, shares of hydrogen fuel cell company Plug Power (NASDAQ: PLUG) jumped up 4.3% through 1:40 p.m. EDT.

You can probably thank J.P. Morgan for that.

Image source

TheMotleyFool

0

Why Protagonist Therapeutics Stock Is Tanking Today

Shares of Protagonist Therapeutics (NASDAQ: PTGX), a clinical-stage biotechnology company, are plummeting today. As of 2:26 p.m. EDT, the stock price has fallen 62.9% in response to news of a

TheMotleyFool

0

As the Nasdaq Drops, Could Five9 Escape Its Deal with Zoom?

The stock market looked poised to close the week on a down note today. Even the Nasdaq Composite (NASDAQINDEX: ^IXIC), which has been an outperformer lately, found itself down three-quarters of a

TheMotleyFool

0

Why Lucid Group Stock Soared Friday

Lucid Group (NASDAQ: LCID) shares are continuing to rise on Friday after the company announced a milestone yesterday, and more investors are talking about the company's technology. As of 12:45 p.m

TheMotleyFool

0

Here's Why Innate Pharma Stock Is Rocketing Higher Today

Shares of Innate Pharma (NASDAQ: IPHA), a clinical-stage biotechnology company, are rocketing higher in response to successful clinical-trial data for an experimental cancer drug called monalizumab

TheMotleyFool

0

These 2 Stocks Are Getting a Lift as Markets Fall

The stock market stayed weak on Friday morning, with the latest news from Wall Street suggesting some worries about consumer confidence. Consumers play a vital role in driving overall economic

TheMotleyFool

0

Why BeiGene's Shares Jumped on Friday

BeiGene (NASDAQ: BGNE), a Chinese pharmaceutical company, saw its shares rise more than 10% in early trading on Friday. The stock, which closed at $385.24 on Thursday, opened Friday at $422 a share

TheMotleyFool

0

Why Uranium Stocks Exploded This Week

Shares of uranium stocks were on fire this week as uranium spot prices continued a steady rise. According to data by Markets Insider, the spot price of uranium is up 65.5% so far this year and has

TheMotleyFool

0